Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants

Objectives To determine if inherited thrombophilia and immunological disorders represent risk factors for small for gestational age infants, and to assess their relationship with neonatal status.

[1]  P. Galan,et al.  5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. , 2000, The British journal of nutrition.

[2]  H. Blom,et al.  Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy , 2000, BJOG : an international journal of obstetrics and gynaecology.

[3]  I. Greer.  Thrombosis in pregnancy: maternal and fetal issues , 1999, The Lancet.

[4]  F. Rosendaal.  Venous thrombosis: a multicausal disease , 1999, The Lancet.

[5]  L. Tengborn,et al.  APC Resistance and other Haemostatic Variables during Pregnancy and Puerperium , 1999, Thrombosis and Haemostasis.

[6]  A. Many,et al.  Increased frequency of genetic thrombophilia in women with complications of pregnancy. , 1999, The New England journal of medicine.

[7]  J. Santolaya-Forgas,et al.  CURRENT CONCEPTS OF FETAL GROWTH RESTRICTION: PART I. CAUSES, CLASSIFICATION, AND PATHOPHYSIOLOGY , 1998, Obstetrics and gynecology.

[8]  I. Greer,et al.  Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy , 1998, Thrombosis and Haemostasis.

[9]  M. Sullivan,et al.  Titration of Antiplatelet Treatment in Pregnant Women at Risk of Preeclampsia , 1998, Thrombosis and Haemostasis.

[10]  E. Carreras,et al.  Coagulation and Fibrinolytic Parameters in Normal Pregnancy and in Pregnancy Complicated by Intrauterine Growth Retardation , 1998, American journal of perinatology.

[11]  D. Kilpatrick.  Factors affecting cardiolipin antibody assays: modification with polyethylene glycol compound , 1998, British journal of haematology.

[12]  L. Regan,et al.  Obstetric complications of antiphospholipid antibodies. , 1997, Current opinion in obstetrics & gynecology.

[13]  P. Ridker,et al.  Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical Perspective , 1997, Annals of Internal Medicine.

[14]  H. Geijn,et al.  Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies , 1997, British journal of obstetrics and gynaecology.

[15]  N. Amino,et al.  Effects of Autoantibodies on the Course of Pregnancy and Fetal Growth , 1997, Obstetrics and gynecology.

[16]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[17]  S. Marret,et al.  Croissance fœtale du prématuré de Haute-Normandie , 1996 .

[18]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[19]  E. Matsuura,et al.  beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. , 1996, Human reproduction.

[20]  P. Moerloose,et al.  Multicenter Evaluation of Nine Commercial Kits for the Quantitation of Anticardiolipin Antibodies , 1995, Thrombosis and Haemostasis.

[21]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[22]  N. Pattison,et al.  Antiphospholipid antibodies in pregnancy: prevalence and clinical associations , 1993, British journal of obstetrics and gynaecology.

[23]  N. Gleicher,et al.  The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy. , 1991, American journal of obstetrics and gynecology.

[24]  C. Labarrere,et al.  Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small‐for‐gestational‐age infants , 1987, British journal of obstetrics and gynaecology.

[25]  T. Khong,et al.  Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants , 1986 .

[26]  P. Gluckman,et al.  The physiology and pathophysiology of intrauterine growth retardation. , 1997, Hormone research.

[27]  E. Matsuura,et al.  beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. , 1996, Human reproduction.

[28]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[29]  M. Fritzler,et al.  Detection of autoantibodies to ss‐a/ro by indirect immunofluorescence using a transfected and overexpressed human 60 kd ro autoantigen in hep‐2 cells , 1995, Journal of clinical laboratory analysis.